Search filters

List of works by Victoria Bae-Jump

A catalogue of cancer-driving mutations in healthy tissue

scientific article published on 22 April 2020

A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer

scientific article

AMG 479, a Novel IGF-1-R Antibody, Inhibits Endometrial Cancer Cell Proliferation Through Disruption of the PI3K/Akt and MAPK Pathways ⬇️

scientific article published on September 1, 2011

Abstract 3609: Metformin treatment outcomes in relation to obesity and cation transporter expression in mouse models of endometrial cancer

scholarly article

Abstract 361: NT1195, a novel biguanide, exhibits superior uterine penetration and anti-tumorigenic efficacy as compared to metformin/phenformin in endometrial cancer

scholarly article

Abstract 364: The dopamine receptor D2 antagonist ONC201 has anti-tumorigenic activity in obesity-driven epithelial ovarian cancer

scholarly article

Abstract 642: Increasing BMI is associated with tumor volume and uterine weight in endometrial cancer

scholarly article

Adjuvant Treatment and Clinical Trials in Elderly Patients With Endometrial Cancer: A Time for Change?

scientific article

Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer

scientific article published in 2022

Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer

scientific article published in 2020

Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.

scientific article

Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer?

scientific article published on 05 November 2020

Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells

scientific article

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

scientific article

Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project.

scientific article published on 8 June 2016

Association between uterine serous carcinoma and breast cancer

scientific article published in July 2004

Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian Cancer

scientific article published on 5 November 2015

Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro

scientific article published in December 2017

Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists

scientific article published in April 2009

Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis

scientific article

Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells

scientific article

Comprehensive care in gynecologic oncology: The importance of palliative care

scientific article

Cytological evaluation correlates poorly with histological diagnosis of vulvar neoplasias

scientific article published on January 2007

Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use.

scientific article

Diet and gut microbiome interactions in gynecologic cancer

scientific article published on 12 September 2020

Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule

scientific article published on 25 July 2017

Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancer

scientific article published on 01 December 2020

Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer

scientific article published on 29 June 2017

Effect of a High-Fat Diet and Metformin on Placental mTOR Signaling in Mice

Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines

scientific article published on 18 May 2016

Endometrial Cancer Survivors' Perceptions of Provider Obesity Counseling and Attempted Behavior Change: Are We Seizing the Moment?

scientific article published on 19 November 2015

Enzymatic cleavage of uracil-containing single-stranded DNA linkers for the efficient release of affinity-selected circulating tumor cells

scientific article

Erratum: Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.

scientific article

Estrogen Induction of Telomerase Activity through Regulation of the Mitogen-Activated Protein Kinase (MAPK) Dependent Pathway in Human Endometrial Cancer Cells ⬇️

scientific article published on February 7, 2013

Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines

scientific article published on 11 May 2006

Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells

scientific article

Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells

scientific article

Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer

scientific article published on 05 March 2016

Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition

scientific article published on 26 November 2019

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

scientific article (publication date: 2013)

Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling

scientific article

Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer

scientific article published on 15 October 2016

Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway.

scientific article

Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese versus lean mice

scientific article published on 8 September 2017

Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells

scientific article published on 2 February 2007

Influences on the perception of elder financial abuse among older adults in Southern California.

scientific article

Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?

scientific article published on 03 March 2020

JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer

scientific article published on March 2015

JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer

scientific article published on 26 August 2016

Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers

scientific article published on 06 December 2019

Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells

scientific article

Metformin and gynecologic cancers

scientific article

Metformin and the risk of endometrial cancer: a population-based cohort study

scientific article

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy

scientific article published on 12 October 2009

Metformin is associated with improved survival in endometrial cancer

scientific article

Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway ⬇️

scientific article published on January 16, 2012

Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials

scientific article published on 3 August 2017

Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer

scientific article published on 15 May 2009

NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo

scientific article published on 21 September 2016

Novasoy and genistein inhibit endometrial cancer cell proliferation through disruption of the AKT/mTOR and MAPK signaling pathways

scientific article published on 15 March 2018

ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitro

ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer In Vitro

scientific article published on 20 October 2020

Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer.

scientific article

Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer

scientific article

Obesity is associated with worse quality of life in women with gynecologic malignancies: an opportunity to improve patient-centered outcomes

scientific article

Outcomes in surgical stage I uterine papillary serous carcinoma

scientific article published on 13 March 2007

Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients

scientific article published on 29 March 2013

Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer

scientific article published on 24 October 2017

Promising novel therapies for the treatment of endometrial cancer

scientific article

Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment.

scientific article

Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.

scientific article published on 24 October 2005

Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis

scientific article

Reversal of obesity-driven aggressiveness of endometrial cancer by metformin

scientific article published on 01 October 2019

Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer

scientific article published on 17 June 2015

SIX1 Oncoprotein as a Biomarker in a Model of Hormonal Carcinogenesis and in Human Endometrial Cancer.

scientific article published on 3 June 2016

SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models

scientific article published on 15 August 2020

SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer

scientific article published on 01 January 2020

Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer

scientific article

Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer

scientific article

Summary of the 2012 American Association for Cancer Research (AACR) Annual Meeting

scientific article published on 12 May 2012

Synergistic effect of rapamycin and cisplatin in endometrial cancer cells

scientific article

Systemic and Local Hormone Therapy for Endometrial Hyperplasia and Early Adenocarcinoma ⬇️

scientific article published on 01 June 2013

Targeted Multiplex Gene Expression Profiling to Measure High-Fat Diet and Metformin Effects on Fetal Gene Expression in a Mouse Model

article

Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer.

scientific article published on 28 January 2016

The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer

scientific article published on 16 October 2015

The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.

scientific article published on 27 December 2005

The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance

scientific article published in April 2014

The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer

scientific article published on 08 April 2016

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer

scientific article published on 6 August 2007

Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cells.

scientific article published on 15 June 2018

Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology

scientific article published on 16 September 2013

Unraveling the mystery of clear cell endometrial cancer

scientific article published on 01 July 2020

Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?

scientific article published on 01 November 2004

VprBP/DCAF1 Regulates the Degradation and Nonproteolytic Activation of the Cell Cycle Transcription Factor FoxM1. ⬇️

scientific article published on 17 April 2017

Paulina is supported by:

About Paulina

Help